Science Explorer Back to mapMap
Discussion
Researcher · SLK-Kliniken Heilbronn · Germany

Sylvia Bochum

Sylvia Bochum publishes mostly in Oncology, Cancer Research and Pulmonary and Respiratory Medicine, on topics such as Cancer Genomics and Diagnostics, Prostate Cancer Treatment and Research and Breast Cancer Treatment Studies.

OpenAlex
World rank
#3,993,589
of 7,710,434 ranked researchers
Rank in Germany
#200,920
of 364,343
Works
25
Citations
691
Citations per work
27.6
h-index
9
i10-index 9Top 65% in Oncology
Sylvia Bochum

What does Sylvia Bochum research?

Sylvia Bochum's work is mostly in Medicine (36%), Biochemistry, Genetics and Molecular Biology (34%).

Health Sciences: 9 works · 35.8% of their workMedicine: 9 works · 35.8% of their workOncology: 4 works · 14.3% of their workPulmonary and Respiratory Medicine: 3 works · 12.9% of their workPathology and Forensic Medicine: 2 works · 8.6% of their workLife Sciences: 9 works · 34.3% of their workBiochemistry, Genetics and Molecular Biology: 9 works · 34.3% of their workCancer Research: 3 works · 12.9% of their workMolecular Biology: 3 works · 11.4% of their workGenetics: 2 works · 10.0% of their workEverything else: 7 works · 29.9% of their workTHEIR WORKSylvia Bochum25works
Life Sciences34%Health Sciences36%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine935.8%
    1. Biochemistry, Genetics and Molecular Biology934.3%
  3. Everything else729.9%
  1. 1Oncology14% of their works
  2. 2Cancer Research13% of their works
  3. 3Pulmonary and Respiratory Medicine13% of their works
  4. 4Molecular Biology11% of their works
  5. 5Genetics10% of their works
  6. 6Pathology and Forensic Medicine9% of their works

Research topics

Which keywords describe Sylvia Bochum's research?

The keywords of their largest research topics: Immunotherapy, Genomic Instability, Neoadjuvant Therapy, Androgen Receptor, Cancer Genomics, Gene Expression, Mutational Signatures and Prostate Cancer.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Immunotherapy82 topics
  2. Genomic Instability72 topics
  3. Neoadjuvant Therapy62 topics
  4. Androgen Receptor51 topic
  5. Cancer Genomics51 topic
  6. Gene Expression52 topics
  7. Mutational Signatures51 topic
  8. Prostate Cancer51 topic
  9. Tumor Microenvironment52 topics
  10. Breast Tumours31 topic
  11. Pancreatic Cancer31 topic
  12. Surgical Complications31 topic
  13. Treatment Response31 topic
  14. DNA Damage21 topic
  15. Estrogen21 topic
  16. Genetic Variation21 topic
  17. Genome-Wide Association21 topic
  18. Immune Checkpoint Blockade21 topic
  19. PD-1 and PD-L121 topic
  20. Receptor21 topic
  21. Repair21 topic

Where does Sylvia Bochum work?

Sylvia Bochum's main affiliation in the publication record is SLK-Kliniken Heilbronn, Germany.

How many publications and citations does Sylvia Bochum have?

OpenAlex counts 25 works and 691 citations for Sylvia Bochum, an h-index of 9, ranking #3,993,589 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Sylvia Bochum. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.